Literature DB >> 1667911

Elevation of plasma endothelin concentrations during endotoxin shock in dogs.

T Nakamura1, K Kasai, Y Sekiguchi, N Banba, K Takahashi, T Emoto, Y Hattori, S Shimoda.   

Abstract

The effect of endotoxin on the release of endothelin, a novel potent vasoconstrictor peptide, was examined in anesthetized dogs and in cultured endothelial cells. Administration of 2.63 mg lipopolysaccharide, E. coli 0111:B4/kg body weight caused shock in the animals and produced a long-lasting increase in the plasma immunoreactive endothelin-1 level that remained higher than the basal level (1.83 pg/ml as mean level) from 30 to 120 min after the injection, with a peak at 90 min (8.15 pg/ml as mean level). In vitro immunoreactive endothelin-1 in a culture medium, in which calf pulmonary artery endothelial cells were incubated in the presence of 10% fetal bovine serum, increased dose dependently with the concentration of added lipopolysaccharide between 0.01 and 10 micrograms/ml. These data indicate that plasma endothelin increases during endotoxin shock and that stimulation by endotoxin, per se, in the presence of serum participates at least partially in the mechanism for its release.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667911     DOI: 10.1016/0014-2999(91)90910-i

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Endothelin-1 production by the canine macrophage cell line DH82: enhanced production in response to microbial challenge.

Authors:  Jeffrey N Divino; Kashmira S Chawla; Christina M da Silva; Ashley M Bjorge; Andrew Brittingham
Journal:  Vet Immunol Immunopathol       Date:  2010-02-13       Impact factor: 2.046

2.  The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.

Authors:  T Hohlfeld; P Klemm; C Thiemermann; T D Warner; K Schrör; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Effect of selective blockade of endothelin ETB receptors on the liver dysfunction and injury caused by endotoxaemia in the rat.

Authors:  H Ruetten; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Comparison of 2 endothelin-receptor antagonists on in vitro responses of equine palmar digital arterial and venous rings to endothelin-1.

Authors:  Ashley M Stokes; Changaram S Venugopal; Giselle Hosgood; Susan C Eades; Rustin M Moore
Journal:  Can J Vet Res       Date:  2006-07       Impact factor: 1.310

5.  Effect of lipopolysaccharides on erythrocyte flow velocity in rat liver.

Authors:  Y Horie; S Kato; E Ohki; H Hamamatsu; D Fukumura; I Kurose; H Suzuki; M Suematsu; S Miura; H Ishii
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

Review 6.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

Review 7.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

8.  Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.

Authors:  G Rossi; G Albertin; A Belloni; L Zanin; M A Biasolo; T Prayer-Galetti; M Bader; G G Nussdorfer; G Palù; A C Pessina
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Endotoxemia Induces IκBβ/NF-κB-Dependent Endothelin-1 Expression in Hepatic Macrophages.

Authors:  Sarah McKenna; Megan Gossling; Alejandro Bugarini; Elizabeth Hill; Aimee L Anderson; Raymond C Rancourt; Natarajan Balasubramaniyan; Karim C El Kasmi; Clyde J Wright
Journal:  J Immunol       Date:  2015-09-04       Impact factor: 5.422

10.  Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat.

Authors:  H Ruetten; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.